BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25558663)

  • 1. [Reproductive problems in women with PCOS, the impact of PAL-1 CARRIERS OF 4G PAI -1 polymorphism and BMI].
    Komsa-Penkova R; Golemanov G; Georgieva G; Slavov N; Popovski K; Ivanov P; Kovacheva K; Atanasova M; Blajev A
    Akush Ginekol (Sofiia); 2014; 53(5):3-9. PubMed ID: 25558663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].
    Komsa-Penkova R; Golemanov G; Georgieva G; Popovski K; Slavov N; Ivanov P; Kovacheva K; Atanasova M; Blajev A
    Akush Ginekol (Sofiia); 2014; 53(6):15-21. PubMed ID: 25672133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S; Huiya Z; Bo L; Wei W; Yongmei G
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
    Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
    Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.
    Sales MF; Sóter MO; Candido AL; Fernandes AP; Oliveira FR; Ferreira AC; Sousa MO; Ferreira CN; Gomes KB
    Gynecol Endocrinol; 2013 Oct; 29(10):936-9. PubMed ID: 23898913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L; Lv H; Wei W; Zhang D; Guan Y
    J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
    Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M
    Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.
    Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C
    J Assist Reprod Genet; 2007 Sep; 24(9):412-8. PubMed ID: 17661167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
    Bagos PG
    Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.
    Zhang TT; Yuan L; Yang YM; Ren Y
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2326-31. PubMed ID: 25219833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population.
    Song X; Ge L; Wang D; Li L; Ma D; Li X; Song X
    J Obstet Gynaecol; 2022 Oct; 42(7):3304-3308. PubMed ID: 36065507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PAL-1 5G/4G polymorphism in patients with systemic lupus erythematosus].
    Savov A; Andonova S; Tanev D; Robeva R; Marincheva Ts; Tomova A; Kumanov P; Rashkov R; Kolarov Z
    Akush Ginekol (Sofiia); 2014; 53(7):13-7. PubMed ID: 25675617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
    Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A
    Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.